On the safety and benefits of repeated intravenous injections of ketamine for depression

Biological Psychiatry

Volumn 72, Issue 4, 2012, Pages

  Blier, Pierre ^a   Zigman, Daniel ^a   Blier, Jean ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Hopital Montfort Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; KETAMINE; LORAZEPAM; MIRTAZAPINE; SODIUM CHLORIDE; TRANYLCYPROMINE; VENLAFAXINE;

ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; BOLUS INJECTION; BONE DENSITY; BRAIN DEPTH STIMULATION; COGNITION; DEPRESSION; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHORIA; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HUMAN; HYPOTENSION; HYPOXEMIA; LETTER; LUNG VENTILATION; MAJOR DEPRESSION; NEUROTOXICITY; NONHUMAN; OXYGEN SATURATION; PATIENT MONITORING; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SINGLE DRUG DOSE; SPINE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING; WEIGHT GAIN;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KETAMINE;

EID: 84864288609     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.02.039     Document Type: Letter

References (16)

1. R.M. Berman, A. Capiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354 (Pubitemid 30109248)
2. C.A. Zarate Jr, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbauch A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864 (Pubitemid 44188478)
3. M. aan het Rot, K.A. Collins, J.W. Murrough, A.M. Perez, D.L. Reich, D.S. Charney, S.J. Mathew Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 2010 139 142
4. N. Diazgranados, L. Ibrahim, N.E. Brutsche, A. Newberg, P. Kronstein, S. Khalife A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Arch Gen Psychiatry 67 2010 793 802
5. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, M. Iwata mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
6. V. Jevtovic-Todorovic, D.F. Wozniak, N. Benshoff, J.W. Olney A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide Brain Res 895 2001 264 267 (Pubitemid 32231166)
7. R.J. Strayer, L.S. Nelson Adverse events associated with ketamine for procedural sedation in adults Am J Emerg Med 26 2008 985 1028
8. M. Bisanzo Jr, K. Nichols, H. Hammerstedt, B. Dreifuss, S.W. Nelson, S. Chamberlain Nurse-administered ketamine sedation in an emergency department in rural Uganda Ann Emerg Med 59 2012 268 275
9. W. Slikker Jr, X. Zou, C.E. Hotchkiss, R.L. Divine, N. Sadovova, N.C. Twaddle Ketamine-induced neuronal cell death in the perinatal rhesus monkey Toxicol Sci 98 2007 145 158 (Pubitemid 47073827)
10. J.A. Clements, W.S. Nimmo, I.S. Grant Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans J Pharmacol Sci 71 1982 539 542 (Pubitemid 12063731)
11. S.M. Green, C.J. Coté Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine Ann Emerg Med 54 2009 181 190
12. N. Li, R.J. Liu, J.M. Dwyer, M. Banasr, B. Lee, H. Son Glutamate N-methyl-D-aspartate antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure Biol Psychiatry 69 2011 754 761
13. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, P.F. Cheng NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses Nature 475 2011 91 95
14. R.J. Schwartzman, G.M. Alexander, J.R. Grothusen, T. Paylor, E. Reichenberger, N. Perreault Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo-controlled study Pain 147 2009 107 115
15. I. Noppers, M. Niesters, L. Aarts, T. Smith, E. Sarton, A. Dahan Ketamine for the treatment of chronic non-cancer pain Expert Opin Pharmacother 11 2010 2417 2429
16. Z.S. Nasreddine, N.A. Phillips, V. Béridian, S. Charbonneau, V. Whitehead, I. Collin The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 2005 695 699 (Pubitemid 41623495)